110 related articles for article (PubMed ID: 35258575)
1. Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality.
Huang CW; Yu AS; Song H; Park JS; Wu SS; Khang VK; Subject CC; Shen E
JAMA Netw Open; 2022 Mar; 5(3):e221455. PubMed ID: 35258575
[TBL] [Abstract][Full Text] [Related]
2. Cohort design to assess the association between post-hospital primary care physician follow-up visits and hospital readmissions.
Kojima N; Bolano M; Sorensen A; Villaflores C; Croymans D; Glazier EM; Sarkisian C
Medicine (Baltimore); 2022 Nov; 101(46):e31830. PubMed ID: 36401424
[TBL] [Abstract][Full Text] [Related]
3. Effect of early dexamethasone on outcomes of COVID-19: A quasi-experimental study using propensity score matching.
Liu WD; Wang JT; Shih MC; Chen KH; Huang ST; Huang CF; Chang TH; Tsai MJ; Kuo PH; Yeh YC; Tsai WC; Pan MY; Li GC; Chen YJ; Lin KY; Huang YS; Cheng A; Chen PY; Pan SC; Sun HY; Ku SC; Chang SY; Sheng WH; Fang CT; Hung CC; Chen YC; Ho YL; Wu MS; Chang SC
J Microbiol Immunol Infect; 2024 Jun; 57(3):414-425. PubMed ID: 38402071
[TBL] [Abstract][Full Text] [Related]
4. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study.
Ayoubkhani D; Khunti K; Nafilyan V; Maddox T; Humberstone B; Diamond I; Banerjee A
BMJ; 2021 Mar; 372():n693. PubMed ID: 33789877
[TBL] [Abstract][Full Text] [Related]
5. Readmission Rates After Acute Respiratory Distress Syndrome in Children.
Keim G; Hsu JY; Pinto NP; McSherry ML; Gula AL; Christie JD; Yehya N
JAMA Netw Open; 2023 Sep; 6(9):e2330774. PubMed ID: 37682574
[TBL] [Abstract][Full Text] [Related]
6. Association between different corticosteroid regimens used in severe SARS-CoV-2 infection and short-term mortality: retrospective cohort study.
González-Castro A; Fernandez A; Cuenca-Fito E; Peñasco Y; Ceña J; Rodríguez Borregán JC
Rev Esp Anestesiol Reanim (Engl Ed); 2024 May; 71(5):379-386. PubMed ID: 38395302
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of tocilizumab on mortality, readmissions, persistent symptoms and lung function in SARS-CoV-2 patients 1 year after hospital discharge: A matched cohort study.
Cardona-Pascual I; Pallero M; Berlana D; Villar A; Montoro-Ronsano JB; Berastegui C
Respir Med Res; 2023 Nov; 84():101064. PubMed ID: 38029650
[TBL] [Abstract][Full Text] [Related]
8. Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort.
Bechman K; Yates M; Mann K; Nagra D; Smith LJ; Rutherford AI; Patel A; Periselneris J; Walder D; Dobson RJB; Kraljevic Z; Teo JHT; Bernal W; Barker R; Galloway JB; Norton S
PLoS One; 2022; 17(1):e0261142. PubMed ID: 35025917
[TBL] [Abstract][Full Text] [Related]
9. Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19.
Chow JH; Rahnavard A; Gomberg-Maitland M; Chatterjee R; Patodi P; Yamane DP; Levine AR; Davison D; Hawkins K; Jackson AM; Quintana MT; Lankford AS; Keneally RJ; Al-Mashat M; Fisher D; Williams J; Berger JS; Mazzeffi MA; Crandall KA;
JAMA Netw Open; 2022 Mar; 5(3):e223890. PubMed ID: 35323950
[TBL] [Abstract][Full Text] [Related]
10. Hospital Readmissions Among Veterans Within 90 Days of Discharge Following Initial Hospitalization for COVID-19.
Weaver FM; Niederhausen M; Hickok A; O'Neill AC; Gordon HS; Edwards ST; Govier DJ; Chen JI; Young R; Whooley M; Hynes DM
Prev Chronic Dis; 2022 Dec; 19():E80. PubMed ID: 36455563
[TBL] [Abstract][Full Text] [Related]
11. Thirty-Day Post-Discharge Outcomes Following COVID-19 Infection.
Kingery JR; Bf Martin P; Baer BR; Pinheiro LC; Rajan M; Clermont A; Pan S; Nguyen K; Fahoum K; Wehmeyer GT; Alshak MN; Li HA; Choi JJ; Shapiro MF; McNairy ML; Safford MM; Goyal P
J Gen Intern Med; 2021 Aug; 36(8):2378-2385. PubMed ID: 34100231
[TBL] [Abstract][Full Text] [Related]
12. Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study.
Mozaffari E; Chandak A; Gottlieb RL; Chima-Melton C; Kalil AC; Sarda V; Der-Torossian C; Oppelt T; Berry M; Amin AN
J Comp Eff Res; 2024 Apr; 13(4):e230131. PubMed ID: 38420658
[No Abstract] [Full Text] [Related]
13. [In patients hospitalized for COVID-19, does dexamethasone reduce 28-days mortality compared to standard treatment?].
Lanthier L; Mayette M; Huard G; Plourde MÉ; Cauchon M
Rev Med Interne; 2020 Nov; 41(11):790-791. PubMed ID: 33077267
[No Abstract] [Full Text] [Related]
14. Home Oxygen After Hospitalization for COVID-19: Results From the Multi-Center OXFORD Study.
Freedman MB; Kim YJ; Kaur R; Jain BV; Adegunsoye AO; Chung YC; DeLisa JA; Gardner JM; Gordon HS; Greenberg JA; Kaul M; Khouzam N; Labedz SL; Mokhlesi B; Rintz J; Rubinstein I; Taylor A; Vines DL; Ziauddin L; Gerald LB; Krishnan JA
Respir Care; 2024 Feb; 69(3):281-289. PubMed ID: 38176902
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone use and mortality in hospitalized patients with coronavirus disease 2019: A multicentre retrospective observational study.
Hoertel N; Sánchez-Rico M; Vernet R; Beeker N; Neuraz A; Alvarado JM; Daniel C; Paris N; Gramfort A; Lemaitre G; Salamanca E; Bernaux M; Bellamine A; Burgun A; Limosin F;
Br J Clin Pharmacol; 2021 Oct; 87(10):3766-3775. PubMed ID: 33608891
[TBL] [Abstract][Full Text] [Related]
16. Observational study of haloperidol in hospitalized patients with COVID-19.
Hoertel N; Sánchez-Rico M; Vernet R; Jannot AS; Neuraz A; Blanco C; Lemogne C; Airagnes G; Paris N; Daniel C; Gramfort A; Lemaitre G; Bernaux M; Bellamine A; Beeker N; Limosin F;
PLoS One; 2021; 16(2):e0247122. PubMed ID: 33606790
[TBL] [Abstract][Full Text] [Related]
17. Recent functional decline and outpatient follow-up after hospital discharge: a cohort study.
Bogler O; Kirkwood D; Austin PC; Jones A; Sinn CJ; Okrainec K; Costa A; Lapointe-Shaw L
BMC Geriatr; 2023 Sep; 23(1):550. PubMed ID: 37697250
[TBL] [Abstract][Full Text] [Related]
18. Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data.
Vaeli Zadeh A; Dinparastisaleh R; Vaezi A; Bandyopadhyay D; Rubinstein I; Baig HZ; Calderon-Candelario R; Hashemi Shahraki A; Kawasaki T; Magnusson JM; Larsson LO; Sharafkhaneh A; Herazo-Maya JD; Lee AS; Mirsaeidi M
Ann Am Thorac Soc; 2024 Mar; 21(3):428-437. PubMed ID: 38134434
[No Abstract] [Full Text] [Related]
19. Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge.
Bernstein EY; Baggett TP; Trivedi S; Herzig SJ; Anderson TS
JAMA Netw Open; 2024 Mar; 7(3):e243387. PubMed ID: 38551564
[TBL] [Abstract][Full Text] [Related]
20. Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study.
Manenti L; Maggiore U; Fiaccadori E; Meschi T; Antoni AD; Nouvenne A; Ticinesi A; Cerundolo N; Prati B; Delsante M; Gandoflini I; Donghi L; Gentile M; Farina MT; Oliva V; Zambrano C; Regolisti G; Palmisano A; Caminiti C; Cocchi E; Ferrari C; Riella LV; Cravedi P; Peruzzi L
PLoS One; 2021; 16(3):e0248276. PubMed ID: 33760858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
